Anti-Parkinson Drugs Global Market Report 2020-30: COVID-19 Growth and Change

Dec 2020| TBR1174A| TBRC (Publisher)

Report Highlights

Including: 1) By Drugs Class: Levodopa/Carbidopa; Dopamine Receptor Agonists; Monoamine Oxidase Type B (MAO-B) Inhibitors; Catechol-O-Methyltransferase (COMT)-inhibitors; Anticholinergics; Other Drugs 

2) By Route of Administration: Oral; Injection; Transdermal
3) By Distribution Channel: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacies

Covering: GlaxoSmithKline plc; Pfizer; UCB; Novartis; Roche

Anti-Parkinson Drugs Global Market Report 2020-30: Covid 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-parkinson drugs market.

This report focuses on anti-parkinson drugs market which is experiencing strong growth. The report gives a guide to the anti-parkinson drugs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the anti-parkinson drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Parkinson Drugs market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anti-parkinson drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The anti-parkinson drugs market section of the report gives context. It compares the anti-parkinson drugs market with other segments of the anti-parkinson drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, anti-parkinson drugs indicators comparison.

Scope

Markets Covered: 1) By Drugs Class: Levodopa/Carbidopa; Dopamine Receptor Agonists; Monoamine Oxidase Type B (MAO-B) Inhibitors; Catechol-O-Methyltransferase (COMT)-inhibitors; Anticholinergics; Other Drugs 
2) By Route of Administration: Oral; Injection; Transdermal 
3) By Distribution Channel: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacies

Companies Mentioned: GlaxoSmithKline plc; Pfizer; UCB; Novartis; Roche

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3 : Global Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4 : Global Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5 : Global Anti-Parkinson Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6 : Global Anti-Parkinson Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7 : Global Anti-Parkinson Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8 : Asia-Pacific, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9 : Asia-Pacific, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10 : China, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11 : China, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12 : India, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13 : India, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14 : Japan, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15 : Japan, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16 : Australia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17 : Australia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18 : Indonesia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19 : Indonesia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20 : South Korea, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21 : South Korea, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22 : Western Europe, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23 : Western Europe, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24 : UK, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25 : UK, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26 : Germany, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27 : Germany, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28 : France, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29 : France, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30 : Eastern Europe, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31 : Eastern Europe, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32 : Russia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33 : Russia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34 : North America, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35 : North America, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36 : USA, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37 : USA, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38 : South America, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39 : South America, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40 : Brazil, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41 : Brazil, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42 : Middle East, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43 : Middle East, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44 : Africa, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45 : Africa, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46 : GlaxoSmithKline plc Financial Performance
  • Table 47 : Pfizer Financial Performance
  • Table 48 : Merck Financial Performance
  • Table 49 : Novartis Financial Performance
  • Table 50 : Roche Financial Performance
  • Figure 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3 : Global Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4 : Global Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5 : Global Anti-Parkinson Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6 : Global Anti-Parkinson Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7 : Global Anti-Parkinson Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8 : Asia-Pacific, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9 : Asia-Pacific, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10 : China, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11 : China, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12 : India, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13 : India, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14 : Japan, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15 : Japan, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16 : Australia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17 : Australia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18 : Indonesia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19 : Indonesia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20 : South Korea, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21 : South Korea, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22 : Western Europe, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23 : Western Europe, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24 : UK, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25 : UK, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26 : Germany, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27 : Germany, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28 : France, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29 : France, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30 : Eastern Europe, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31 : Eastern Europe, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32 : Russia, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33 : Russia, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34 : North America, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35 : North America, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36 : USA, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37 : USA, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38 : South America, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39 : South America, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40 : Brazil, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41 : Brazil, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42 : Middle East, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43 : Middle East, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44 : Africa, Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45 : Africa, Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46 : GlaxoSmithKline plc Financial Performance
  • Figure 47 : Pfizer Financial Performance
  • Figure 48 : Merck Financial Performance
  • Figure 49 : Novartis Financial Performance
  • Figure 50 : Roche Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report